ID   YYXY-M4
AC   CVCL_E9ED
DR   CCRID; 4201PAT-CCTCC02508
DR   CCRID; 4201PAT-CCTCC02647
RX   Patent=CN118546887A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023217.
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Patent=CN118546887A
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,24
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 16,20
ST   D19S433: 14
ST   D1S1656: 11,15
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D6S1043: 12,14
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24,27
ST   Penta D: 9,12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C122687; Cytogenetically normal acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   Patent=CN118546887A;
RA   Li, Feng-Lin
RA   Zhuang, Hai-Hui
RA   Lu, Ying
RA   Lin, Qing-Qing
RA   Chen, Dong
RT   "Nuclear normal human acute myeloid leukemia cell strain and
RT   application thereof.";
RL   Patent number CN118546887A, 27-Aug-2024.
//